NEW AGE FOR NUCLEAR MEDICINE
Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of radiopharmaceuticals at Ipsen.
Recent News
PERT Update: Addressing Current Shortages
At Neuroendocrine Cancer UK, we have been actively collaborating with our charity partners to tackle the urgent need to resolve the ongoing shortages of Pancreatic Enzyme Replacement Therapy (PERT). Our joint efforts have resulted in significant strides towards...
June Highlights
Thanks to you, this is what we have been able to achieve this month. - - 🎉 June Highlights! 🎉 💊 We've been working...
Announcing the 2024 Pump-Priming Grant Winner
As part of our ‘Advancing Neuroendocrine Cancer Research’ campaign, and in collaboration with the United Kingdom & Ireland Neuroendocrine Tumour Society (UKINETS) we are funding one pump-priming grant in 2024. This grant aims to provide pump-priming funds to...